Skip to main content

Table 1 Baseline characteristics of the study participants

From: Multiple cardiometabolic diseases enhance the adverse effects of hypoalbuminemia on mortality among centenarians in China: a cohort study

 

Total

Serum albumin

P value

Q4 (≥ 41.3 g/L)

Q3 (38.9–41.2 g/L)

Q2 (36.2–38.9 g/L)

Q1 (< 36.2 g/L)

Age(year), median(IQR)

102 (101–104)

102 (101–104)

102 (101–105)

102 (101–105)

102 (101–105)

0.026

Female, n(%)

822 (82.0)

203 (84.2)

213 (83.5)

197 (79.1)

209 (81.3)

0.440

Han ethnicity, n(%)

883 (88.1)

213 (88.4)

217 (85.1)

225 (90.4)

228 (88.7)

0.318

Widowed, n(%)

836 (83.4)

199 (82.6)

220 (86.3)

208 (83.5)

209 (81.3)

0.485

Illiterate, n(%)

915 (91.3)

217 (90.0)

236 (92.5)

223 (89.6)

239 (93.0)

0.762

Never smoking, n(%)

896 (89.4)

215 (89.2)

232 (91.0)

223 (89.6)

226 (87.9)

0.736

Never alcohol drinking, n(%)

836 (83.4)

201 (83.4)

217 (85.1)

212 (85.1)

206 (80.2)

0.386

ADL disability, n(%)

140 (14.0)

7 (2.9)

29 (11.4)

26 (10.4)

78 (30.4)

 < 0.001

Hypertension, n(%)

744 (74.3)

202 (83.8)

199 (78.0)

176 (70.7)

167 (65.0)

 < 0.001

Diabetes, n(%)

96 (9.6)

29 (12.0)

17 (6.7)

23 (9.2)

27 (10.5)

0.216

CHD, n(%)

41 (4.1)

13 (5.4)

11 (4.3)

10 (4.0)

7 (2.7)

0.512

Stroke, n(%)

22 (2.2)

5 (2.1)

7 (2.7)

9 (3.6)

1 (0.4)

0.085

Dyslipidemia, n(%)

230 (23.0)

59 (24.5)

52 (20.4)

55 (22.1)

64(24.9)

 < 0.001

BMI(kg/m2), mean ± SD

18.04 ± 3.41

18.46 ± 3.24

18.13 ± 3.25

18.27 ± 3.20

17.33 ± 3.79

0.001

SBP(mmHg), mean ± SD

152.57 ± 24.43

159.90 ± 24.85

154.99 ± 22.46

151.51 ± 24.59

144.31 ± 23.29

 < 0.001

DBP(mmHg), mean ± SD

75.75 ± 12.94

79.99 ± 14.02

77.09 ± 11.37

74.62 ± 12.13

71.53 ± 12.72

0.001

CRP (mg/L), median (IQR)

0.19 (0.08–0.43)

0.13 (0.05–0.30)

0.19 (0.09–0.33)

0.17 (0.07–0.40)

0.33 (0.14–0.99)

 < 0.001

Haemoglobin (g/L), mean ± SD

113.05 ± 16.35

120.73 ± 15.44

115.73 ± 13.69

112.17 ± 15.30

104.04 ± 16.27

 < 0.001

FBG(mmol/L), median(IQR)

4.82 (4.26–5.64)

4.82 (4.20–5.25)

4.82 (4.32–5.62)

4.82 (4.23–5.67)

4.97 (4.27–5.85)

0.225

eGFR(mL/min/1.73 m2), median (IQR)

76.42 (48.62–100.96)

80.87 (47.99–103.46)

76.42 (49.82–97.74)

71.52 (46.88–99.78)

77.72 (49.32–101.18)

0.724

Total protein (g/L), mean ± SD

68.65 ± 6.27

73.00 ± 5.88

69.65 ± 5.18

67.62 ± 4.90

64.73 ± 5.87

 < 0.001

ALT (UI/L), median(IQR)

9.20 (7.20–12.00)

10.00 (8.20–12.95)

9.40 (7.70–11.80)

8.50 (7.10–12.35)

8.20 (6.40–10.85)

0.086

AST (UI/L), median(IQR)

20.60 (17.50–24.40)

21.50 (18.90–25.65)

20.70 (17.95–24.60)

20.20 (17.40–23.60)

19.40 (16.60–23.90)

0.396

  1. ADL activities of daily living, ALT alanine transaminase, AST aspartate aminotransferase, BMI body mass index, CHD coronary heart diseases, CRP C-reactive protein, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, FBG fasting blood glucose, HDL high-density lipoprotein, IQR interquartile ranges, LDL low-density lipoprotein, SBP systolic blood pressure, SD standard deviation, TC total cholesterol, TG triglycerides